Amneal and Impax to divest 10 to close deal

Amneal and Impax intend to conclude their merger on 4 May, after receiving approval to proceed with the deal from the US Federal Trade Commission (FTC) on condition that the pair divest 10 products. Agreements have been struck with ANI Pharmaceutical, G&W Laboratories and Perrigo for the divestments.